Association for Research in Vision and Ophthalmology
Association for Research in Vision and Ophthalmology
May 01, 2018
1 min read
Save

Targeted laser photocoagulation treats select cases of diabetic retinopathy

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

HONOLULU — Targeted retinal photocoagulation may be used to treat severe nonproliferative diabetic retinopathy as well as some cases of proliferative diabetic retinopathy, according to a poster presented here.

Pallavi Singh, MD, of Dr. Rajendra Prasad Centre for Ophthalmic Sciences, New Delhi, and colleagues undertook a nonrandomized, prospective, interventional study of 30 treatment-naive eyes with NPDR or PDR without high-risk characteristics (HRC) treated with targeted retinal photocoagulation over capillary nonperfusion areas.

Areas of treatment were identified with Optos ultra-widefield fluorescein angiography.

“We delineated the capillary nonperfusion areas and performed targeted laser in these particular areas to see the effect of what it would be like to do just a targeted laser and not a full scatter laser like what is done conventionally for these patients,” Singh told Healio.com/OSN.

In the treated patients, visual acuity statistically significantly improved at 6 weeks (P = .001) and was stable at 6 months (P = .003) compared with baseline. Contrast sensitivity increased after photocoagulation at 6 weeks (P = .001) and 6 months (P = .006) compared with baseline. Central macular thickness did not change.

“Especially for patients with NPDR or PDR without HRC, we can go ahead and do a targeted laser and not a full scatter laser, and we can avoid all the side effects that are usually seen with the scatter laser,” Singh said. by Patricia Nale, ELS

Reference:

Singh P, et al. Ultra-widefield fluorescein angiography guided targeted retinal photocoagulation in diabetic retinopathy. Presented at: Association for Research in Vision and Ophthalmology annual meeting; April 28-May 3, 2018; Honolulu.

Disclosure: Singh reports no relevant financial disclosures.